chevron_leftBack
As of 10 June 2026, GenMont Biotech InCorp. has a market cap of $48.31M USD, ranking #30798 globally and #1856 in Taiwan.
It ranks #2777 in the Healthcare sector, and #162 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$48.31MUSD
1.53B TWD
Enterprise Value
$44.06MUSD
1.39B TWD
Revenue (TTM)
$12.7MUSD
401.23M TWD
EBITDA (TTM)
$3.82MUSD
120.57M TWD
Net Income (TTM)
$1.81MUSD
57.2M TWD
EBITDA Margin
30%
Profit Margin
14%
PE Ratio
26.9
PS Ratio
3.8
PB Ratio
1.1
EV/EBITDA
11.2
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.3% | -0.8% | -4.1% | -3.8% | -5.3% | -7.8% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
3164
景岳生物科技股份有限公司
ISIN: TW0003164000
Shares Out.:
Shares Outstanding:
86.01M1
Shares Float:
80.052M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
17.70 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About GenMont Biotech InCorp.
GenMont Biotech Incorporation engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan, Singapore, Mainland Chinese, and internationally. The company offers OEM and ODM services, including functional probiotic raw materials, capsules, powder, tablets, and liquid products. GenMont Biotech Incorporation was founded in 2000 and is based in Tainan City, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6472
|
$1.68B
3K%
52.95B TWD
|
17.9
|
|
TWSE: 1707
|
$534.4M
1K%
16.89B TWD
|
14.0
|
|
TWSE: 7780
|
$474.2M
882%
14.99B TWD
|
36.5
|
|
TPEX: 8436
|
$413.17M
755%
13.06B TWD
|
13.7
|
|
TPEX: 4128
|
$290.35M
501%
9.18B TWD
|
-
|
|
TPEX: 7832
|
$243.19M
403%
7.69B TWD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.19B
77K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
61K%
|
-
|
|
SHE: 002001
|
$15.85B
33K%
107.34B CNY
|
16.0
|
|
NSE: CIPLA
|
$11.16B
23K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.04B
23K%
1.05T INR
|
22.7
|
|
SHE: 002653
|
$9.09B
19K%
61.6B CNY
|
80.6
|
chevron_leftBack